"Patients with metastatic hormone-sensitive prostate cancer benefited from treatment with darolutamide plus ADT and docetaxel regardless of age," said Joan Carles, MD, PhD.
Bonus Apr 08, 1994 May 03, 1994 Mar 24, 1994 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Dec 04, 1992 Dec 22, 1992 Sep 30, 1992 Bonus Ratio: 1 share(s) for every 1 shares held Dr. Reddy's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback